The health and economic effects of HPV DNA screening in The Netherlands

International Journal of Cancer. Journal International Du Cancer
Johannes BerkhofChris J Meijer

Abstract

We studied the health and economic effects of human papillomavirus (HPV) DNA testing in cervical screening using a simulation model. The key data source was a Dutch longitudinal screening trial. We compared cytological testing with repeat cytology (for borderline/mildly abnormal smears) to HPV testing with cytology triage (for HPV-positive smears), combination testing (combined HPV and cytology) and cytological testing with HPV triage (for borderline/mildly abnormal smears). We varied the screening interval from 5 to 10 years. The main outcome measures were the number of cervical cancer cases, the number of quality-adjusted life years (QALYs), and the incremental cost-effectiveness ratio (ICER). The base-case estimates were accompanied with ranges across 118 calibrated parameter settings (calibration criteria: cervical intraepithelial neoplasia 2/3, cancer and mortality rates). In comparison to 5-yearly cytology, 5-yearly HPV testing with cytology triage gave a reduction in the number of cancer cases of 23% (range, 9-27%). The reduction was 26% (range, 10-29%) for combination testing and 3% (range, -1 to 8%) for cytology with HPV triage. For strategies with primary HPV testing, the model also estimated a reduction in cancer cas...Continue Reading

References

Sep 1, 1991·British Journal of Cancer·G J van Oortmarssen, J D Habbema
Oct 1, 1981·Gynecologic Oncology·J BoyceJ H Nelson
Apr 1, 1993·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·A G Ostör
Mar 6, 1998·Obstetrical & Gynecological Survey·E H HopmanT J Helmerhorst
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Mar 21, 2001·Cytopathology : Official Journal of the British Society for Clinical Cytology·A HerbertJ A Smith
Feb 7, 2002·Journal of the National Cancer Institute·M Elske van den Akker-van MarleJ Dik F Habbema
May 4, 2002·JAMA : the Journal of the American Medical Association·Jeanne S MandelblattKeerti Shah
Jan 2, 2003·Journal of the National Cancer Institute·Mark E ShermanMark Schiffman
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Apr 1, 2004·International Journal of Cancer. Journal International Du Cancer·Nicole W J BulkmansChris J L M Meijer
Apr 22, 2004·Journal of the National Cancer Institute·Sue J GoldieEduardo Franco
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Johannes BerkhofChris J L M Meijer
Jun 16, 2005·Journal of the National Cancer Institute·Jane J KimSue J Goldie
Oct 12, 2005·International Journal of Cancer. Journal International Du Cancer·Johannes BerkhofChris J L M Meijer
Apr 6, 2006·International Journal of Cancer. Journal International Du Cancer·Jack CuzickThomas Iftner
Jun 8, 2006·Journal of the National Cancer Institute·Guglielmo RoncoUNKNOWN New Technologies for Cervical Cancer Working Group
Jun 15, 2006·British Journal of Cancer·H C KitchenerUNKNOWN ARTISTIC Trial Study Group
Jul 4, 2006·The Lancet Oncology·Guglielmo RoncoUNKNOWN New Technologies for Cervical Cancer screening Working Group
Jul 13, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Johannes BerkhofChris J L M Meijer
Nov 30, 2006·International Journal of Cancer. Journal International Du Cancer·Matejka ReboljDik Habbema
Mar 8, 2007·British Journal of Cancer·N W J BulkmansUNKNOWN POBASCAM Study Group
Mar 14, 2007·International Journal of Cancer. Journal International Du Cancer·Saskia BulkChris J L M Meijer
May 15, 2007·The New England Journal of Medicine·Suzanne M GarlandUNKNOWN Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators
May 29, 2007·American Journal of Epidemiology·Jane J KimSue J Goldie
Oct 16, 2007·International Journal of Cancer. Journal International Du Cancer·Peter BistolettiJoakim Dillner
Oct 19, 2007·The New England Journal of Medicine·Marie-Hélène MayrandUNKNOWN Canadian Cervical Cancer Screening Trial Study Group
Oct 19, 2007·The New England Journal of Medicine·Pontus NauclerJoakim Dillner
Mar 4, 2008·Journal of the National Cancer Institute·Jeremy D Goldhaber-FiebertSue J Goldie

❮ Previous
Next ❯

Citations

Jan 22, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M G DijkstraC J L M Meijer
Jun 19, 2012·Cancer Causes & Control : CCC·Esther W de Bekker-GrobMarjolein van Ballegooijen
Jun 20, 2013·Expert Opinion on Medical Diagnostics·Rogier J N T M LitjensArnold-Jan Kruse
Aug 7, 2013·Gaceta sanitaria·Vanesa Rodríguez-Salés Silvia de Sanjosé
Dec 6, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Shalini Kulasingam, Laura Havrilesky
Apr 13, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G SroczynskiU Siebert
Dec 22, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·James F O'MahonyInge M C M de Kok
Mar 14, 2016·Cancer Causes & Control : CCC·Steffie K NaberMarjolein van Ballegooijen
Jan 19, 2012·BJOG : an International Journal of Obstetrics and Gynaecology·J van RosmalenM van Ballegooijen
Oct 4, 2011·International Journal of Cancer. Journal International Du Cancer·Tazio VanniRosa Legood
Jul 5, 2013·International Journal of Cancer. Journal International Du Cancer·Inge M C M de KokMarjolein van Ballegooijen
Oct 24, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Azin NahvijouAhmad Barati Marnani
Dec 9, 2014·International Journal of Cancer. Journal International Du Cancer·Margaretha A VinkJohannes Berkhof
Sep 17, 2015·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Leonidas GeorgalisMireia Diaz
Jan 20, 2018·International Journal of Cancer. Journal International Du Cancer·Inge M C M de KokMarjolein van Ballegooijen
Apr 24, 2018·European Journal of Public Health·Mireia DiazSilvia de Sanjosé
May 1, 2011·Expert Review of Obstetrics & Gynecology·Lyndsay A RichardsonEduardo L Franco
Jul 4, 2020·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Yenny Urrea CosmeIsabel C Garcés-Palacio
Mar 11, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Albertus T HesselinkPeter J F Snijders
Jun 26, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lise M A De StrooperDaniëlle A M Heideman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.